Skip to main content

and
  1. No Access

    Article

    Childhood cancer survivor care: development of the Passport for Care

    Numerous calls for improvement in the quality of follow-up care provided to cancer survivors, particularly survivors of childhood cancer have been issued by key health organizations in the USA; the Passport fo...

    David G. Poplack, Michael Fordis, Wendy Landier in Nature Reviews Clinical Oncology (2014)

  2. No Access

    Article

    Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration

    Purpose: Intrathecal methotrexate achieves high concentrations in cerebrospinal fluid (CSF), but drug distribution throughout the subarachnoid space after an intralumbar dose is limited. The objective of this st...

    Frank M. Balis, Susan M. Blaney, Cynthia L. McCully in Cancer Chemotherapy and Pharmacology (2000)

  3. No Access

    Article

    New cytotoxic drugs for intrathecal administration

    Susan M. Blaney, David G. Poplack in Journal of Neuro-Oncology (1998)

  4. No Access

    Article

    Pharmacologic strategies for the treatment of meningeal malignancy

    There have been significant strides in the treatment and prevention of meningeal cancer, particularly meningeal leukemia, during the past thirty years. These advantages are a direct result of innovative therap...

    Susan M. Blaney, David G. Poplack in Investigational New Drugs (1996)

  5. No Access

    Article

    Intrathecal administration of topotecan in nonhuman primates

    The cerebrospinal fluid (CSF) pharmacokinetics of topotecan were studied in a nonhuman primate model following intraventricular administration of 0.1 mg. Lactone and total drug concentrations were measured usi...

    Susan M. Blaney, Diane E. Cole, Karen Godwin in Cancer Chemotherapy and Pharmacology (1995)

  6. No Access

    Article

    Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the Rhesus monkey

    Piroxantrone is an anthrapyrazole derivative with broad anti-tumor activityin vitro and less cardiac toxicity than the anthracyclines. The metabolic pathways and central nervous system penetration of piroxantrone...

    Stacey L. Berg, Frank M. Balis, Karen S. Godwin in Investigational New Drugs (1993)

  7. No Access

    Article

    Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkey

    The pharmacokinetics of the polyethylene glycol-conjugated form of the enzymel-asparaginase and the depletion ofl-asparagine from the plasma and cerebrospinal fluid (CSF) following an i.m. dose of 2500 IU/m2 PEG-

    Stacey L. Berg, Frank M. Balis, Cynthia L. McCully in Cancer Chemotherapy and Pharmacology (1993)

  8. No Access

    Article

    Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate

    Arabinosyl-5-azacytosine (AAC), a new nucleoside antimetabolite, is broadly active in preclinical tumor screening evaluations. To assess the potential for intrathecal use of this drug, we studied the toxicity ...

    Richard L. Heideman, Cynthia McCully, Frank M. Balis in Investigational New Drugs (1993)

  9. No Access

    Article

    Intrathecal 5-fluorouracil in the rhesus monkey

    Because meningeal spread of both leukemia and solid tumors remains a difficult therapeutic problem, there is a compelling need to develop new agents for intrathecal administration. 5-Fluorouracil (5FU), an act...

    Stacey L. Berg, Frank M. Balis, Cynthia L. McCully in Cancer Chemotherapy and Pharmacology (1992)

  10. No Access

    Article

    A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia

    A phase II pediatric trial of a continuous intravenous infusion of 6-mercaptopurine (6MP) in patients with refractory leukemia was performed. The dosing schedule, 50 mg m−2 h−1 for 48 h, was based on the results ...

    Peter C. Adamson, Solomon Zimm, Abdel H. Ragab in Cancer Chemotherapy and Pharmacology (1992)

  11. No Access

    Article

    A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors

    A phase II pediatric trial of a continuous intravenous infusion of 6-mercaptopurine (6-MP) in patients with refractory solid tumors or lymphoma was performed. The dosing schedule of 50 mg/m2 per hour for 48 h was...

    Peter C. Adamson, Solomon Zimm, Abdel H. Ragab in Cancer Chemotherapy and Pharmacology (1990)

  12. No Access

    Article

    Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas

    Frank M. Balis, Andrea Gillespie, Jean Belasco in Investigational New Drugs (1990)

  13. No Access

    Article

    An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys

    Monoclonal antibody WT1 (anti-CD7), conjugated to ricin A chain, was administered intrathecally to rhesus monkeys to test its suitability for use in the therapy of leukemic meningitis. The WT1-SMPT-dgRTA conju...

    Andrew A. Hertler, David M. Schlossman in Cancer Immunology, Immunotherapy (1989)

  14. No Access

    Chapter

    New methods of administering old drugs: IV infusion of mercaptopurine

    In order to maximize an anti-neoplastic agent’s activity it is essential to consider the drug’s pharmacokinetics. The importance of route and schedule of administration has been well exemplified by the experie...

    Solomon Zimm, David G. Poplack in The Role of Pharmacology in Pediatric Oncology (1987)

  15. No Access

    Chapter

    Pharmacologic approaches to the treatment of central nervous system malignancy

    The identification of effective chemotherapy for the treatment of central nervous system (CNS) malignancy poses a major challenge to the oncologist. Although anti-neoplastic chemotherapy has become a mainstay ...

    David G. Poplack, Riccardo Riccardi in The Role of Pharmacology in Pediatric Oncology (1987)

  16. No Access

    Chapter

    Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity

    During the past decade there has been increasing interest in the role of the mononuclear phagocyte in the immune response. It is now appreciated that these cells subserve a variety of important immunologic fun...

    David G. Poplack, Diane E. Cole, Usha Srinivasan in Immunology (1984)

  17. No Access

    Article

    Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)

    The ability of cis-DDP and several analogs to enter the CSF was investigated in rhesus monkeys that had subcutaneoulsy implanted Ommaya reservoirs connected to catheters in each monkey's fourth ventricle. Plas...

    Paul E. Gormley, Diamon Gangji, James H. Wood in Cancer Chemotherapy and Pharmacology (1981)

  18. Article

    IMMUNODEFICIENCY IN LYMPHOHISTIOCYTOSIS: DEFECTIVE CELLULAR IMMUNITY IN ASSOCIATION WITH HYPERLIPIDEMIA

    Lymphohistiocytosis (LH) is a familial syndrome characterized by abnormal accumulation of non-malignant histiocytes in lymph nodes, liver, and spleen, erythrophagocytosis, hepatoaplenomegaly, recurrent fever, ...

    Stephan Ladisch, David G Poplack, Betty J Holiman, R Michael Blaese in Pediatric Research (1977)